Product NDC: | 0245-0136 |
Proprietary Name: | Trianex |
Non Proprietary Name: | triamcinolone acetonide |
Active Ingredient(s): | .5 mg/g & nbsp; triamcinolone acetonide |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0245-0136 |
Labeler Name: | Upsher-Smith Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA089595 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110527 |
Package NDC: | 0245-0136-66 |
Package Description: | 20 TUBE in 1 CARTON (0245-0136-66) > 3 g in 1 TUBE |
NDC Code | 0245-0136-66 |
Proprietary Name | Trianex |
Package Description | 20 TUBE in 1 CARTON (0245-0136-66) > 3 g in 1 TUBE |
Product NDC | 0245-0136 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | triamcinolone acetonide |
Dosage Form Name | OINTMENT |
Route Name | TOPICAL |
Start Marketing Date | 20110527 |
Marketing Category Name | ANDA |
Labeler Name | Upsher-Smith Laboratories, Inc. |
Substance Name | TRIAMCINOLONE ACETONIDE |
Strength Number | .5 |
Strength Unit | mg/g |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |